MULTICENTER RANDOMIZED PHASE II STUDY OF R-MPV-A CHEMOIMMUNOTHERAPY WITH OR WITHOUT LOW-DOSE WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: NRG/ RTOG 1114 Article Other Scholarly Work

Omuro, A, Deangelis, L, Polley, MC et al. (2025). MULTICENTER RANDOMIZED PHASE II STUDY OF R-MPV-A CHEMOIMMUNOTHERAPY WITH OR WITHOUT LOW-DOSE WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: NRG/ RTOG 1114 . Neuro-Oncology, 27(Supplement_3), iii15-iii16. 10.1093/neuonc/noaf193.045

Open Access International Collaboration

cited authors

  • Omuro, A; Deangelis, L; Polley, MC; Correa, D; Wefel, JS; Bovi, JA; Rosenblum, M; Corn, BW; Aneja, S; Grommes, C; Peereboom, DM; Lallana, E; Werner-Wasik, M; Rogers, C; Iwamoto, F; Yu, H; Donnelly, E; Struve, TD; Won, M; Mehta, MP

authors

publication date

  • October 1, 2025

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3201 Cardiovascular Medicine and Haematology
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • 6.5 Radiotherapy and other non-invasive therapies
  • Brain Cancer
  • Clinical Neurology
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Health Disparities
  • Hematology
  • Life Sciences & Biomedicine
  • Lymphatic Research
  • Neurosciences
  • Neurosciences & Neurology
  • Oncology
  • Rare Diseases
  • Science & Technology

Digital Object Identifier (DOI)

start page

  • iii15

end page

  • iii16

volume

  • 27

issue

  • Supplement_3